Wednesday May 17 2023
Welcome / Introduction
- Welcome / Introduction with Ritesh Mistry, PhD
- ❏ Watch this presentation
Keynote Lectures: The value of computational modeling in regulatory decision making for tobacco and nicotine products
- “Contributions of computational modeling to tobacco regulation decision making – present and future” with Kenneth E. Warner, PhD
- ❏ Watch this presentation❏ Slides from this presentation
- “The use of modeling in tobacco regulatory science: insights from CTP” with Brian King, PhD, MPH
- ❏ Watch this presentation❏ Slides from this presentation
- Keynote Q & A with Brian King, PhD, MPH and Kenneth E. Warner, PhD
- ❏ Watch this presentation
Session One: Very low nicotine content cigarettes: Regulatory considerations and empirical evidence
- Session One Introduction with Luz Sanchez Romero, MD, MSc, PhD
- ❏ Watch this presentation
- “Overview of FDA regulatory framework for very low nicotine cigarettes” with Mitch Zeller, JD
- ❏ Watch this presentation❏ Slides from this presentation
- “Nicotine addiction: from biology to regulatory policy” with Neal Benowitz, MD
- ❏ Watch this presentation❏ Slides from this presentation
- “Reducing nicotine in cigarettes: the science ” with Dorothy Hatsukami, PhD
- ❏ Watch this presentation❏ Slides from this presentation
- Session One Q & A with Dorothy Hatsukami, PhD and Mitch Zeller, JD
- ❏ Watch this presentation
Session Two: Modeling the impact of very low nicotine content cigarette regulations
- Session Two Introduction with Ruoyan Sun, PhD
- ❏ Watch this presentation
- “The public health gains had cigarette companies chosen to sell very low nicotine cigarettes” with David Levy, PhD
- ❏ Watch this presentation❏ Slides from this presentation
- “Modeling the potential impact of instantaneous versus gradual VLNC regulation on smoking prevalence and associated mortality” with David Mendez, PhD
- ❏ Watch this presentation❏ Slides from this presentation
- “Tobacco endgame in New Zealand: could it achieve less than 5% prevalence by 2025, and what are the health and productivity gains?” with Tony Blakely, MBChB, MPH, PhD
- ❏ Watch this presentation❏ Slides from this presentation
- “Modeling approach to quantify the potential public health effects of reducing nicotine levels in cigarettes in the United States” with Esther Salazar, PhD
- ❏ Watch this presentation❏ Slides from this presentation
- Session Two Q & A with Tony Blakely, MBChB, MPH, PhD, David Levy, PhD, David Mendez, PhD and Esther Salazar, PhD
- ❏ Watch this presentation